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1. Introduction
  Malaria is a major problem for European travelers to 
endemic regions: between 10 and 15 million travelers 
visit annually these areas and between 12 000 and 15 000 
cases are introduced in Europe especially from African 
countries[1]. In Romania, malaria was eradicated in 1963[2] 
and during 1980-2007 approximately 20 imported cases were 
detected annually[3]. The aim of our short communication is 
to present 2 interesting cases of imported malaria detected 
in Timisoara City (Western Romania). 
  Hospital medical records of 2 malaria patients admitted to 
the Municipal Hospital and Infectious Diseases (ID) Hospital 
in Timisoara, Romania, between March 2010-March 2011, 
were retrospectively investigated. Epidemiological, clinical, 
therapeutic data and laboratory test results were extracted 
and processed.    
2. Case reports
2.1. Case 1
  A 20-year female student made a leisure trip to India 
during the summer (August) of 2009. Patient did not follow 
any chemoprophylaxis prior or during her travel. The 
onset of the disease was seven months after she returned 
from India, with fever paroxysms. Prior to addressing the 
hospital, severe thrombocytopenia and grade 4 neutropenia 
were ambulatory detected. After 4 days, the patient was 
admitted to the Municipal Hospital. Her complete clinical 
picture at hospital admission included fever (39.7 曟)
with shivers, sweating, headache, myalgias, pain in the 
left hypochondrium, nausea, vomiting, cutaneous and 
mucosal pallor, hepatomegaly, splenomegaly and facial 
pruriginous eruption. The relevant laboratory tests at 
admission indicated the following results: erythrocyte count 
-4 410 000 cells/毺L, leukocyte count -2 310 cells/毺L with 
neutrophils of 17.8%, thrombocyte count -44 000 cells/毺L,
hemoglobin -13.2 g/dL, erythrocyte sedimentation rate 
-15 mm/hour, alanine aminotransferase -68 U/L, aspartate 
aminotransferase -62 U/L. During the course of the disease, 
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further laboratory tests revealed a C-reactive protein 
of 29 mg/L and the presence of anti-nuclear and anti-
thrombocyte antibodies. Her medical history revealed that 
she has been known with thrombocytopenia since 2003, but 
no investigation were undertaken to establish its etiology. 
Three days after her admission, the bone marrow aspirate 
revealed the presence of Plasmodium parasites in her red 
blood cells. Examinations of thin and thick blood smears 
(Giemsa staining) evidenced parasitized erythrocytes typical 
for an infection with Plasmodium vivax (P. vivax) species 
(mature schizonts, micro and macrogametocytes) with well 
evidenced Schuffner’s dots (Figure 1A). Once the infectious 
etiology was established, the patient was transferred to the 
ID Hospital with the diagnosis: mild anemia with hemolytic 
component, grade 4 neutropenia, severe form of idiopathic 
thrombocytopenic purpura (lTP), parasitic infection with
P. vivax and a possible collagen disorder. In the ID 
hospital, the patient was hospitalized for 19 days, and 
received specific therapy with the following available 
drugs: quinine sulfate (3 伊 600 mg per day; the first 2 days) 
hydroxychloroquine (Plaquenil) (4 伊 200 mg per day -in 
the 3rd day and 2 伊200 mg per day -during days 4 and 5) 
and primaquine (2 伊 7.5 mg per day -during days 4-17). 
The outcome was favorable and the patient was discharged 
with the following recommendations: reexamination after 3 
months and ambulatory supervision for a 3-year period.        
A
B
Figure 1 Giemsa stained thin blood smear showing (A) a mature 
schizont of P. vivax species and Schuffner’s dots in the infected 
erythrocyte (case 1), and (B) 3 ring forms of P. falciparum species in 
the same infected erythrocyte (case 2).
2.2. Case 2
  A 60-year female patient, professionally retired, known 
to suffer for 2 years of rheumatoid polyarthritis and treated 
during this period with methotrexate was admitted to the ID 
Hospital in Timisoara for a febrile syndrome accompanied 
by shivers and digestive symptoms. The onset of the disease 
was 3 days prior hospitalization. From her medical history 
we depicted that she returned 2 weeks before admission 
from a trip to Republic of Ghana (February 2011), where 
she stayed for 2 weeks. The patient followed an incomplete 
chemoprophylaxis (hydroxychloroquine, 400 mg once, one 
week prior her departure). Physical examination performed 
at admission revealed that patient was afebrile but in a 
bad general condition. The clinical picture consisted of 
fever (39.5 曟) accompanied by shivers, sweating, nausea, 
vomiting, diarrhea, loss of appetite, cold and cyanotic limbs, 
tachycardia alternating with bradycardia, hypotension, 
hepatomegaly, oligoanuria, icterus, altered mental status 
and nystagmus. At admission, the erythrocyte count was 
4 680 000 cells/毺L, leukocyte count  -2 480 cells/毺L with 
neutrophils -86.3%, thrombocyte count -38 000 cells/μL, 
hemoglobin -15.5 g/dL, erythrocyte sedimentation rate 
-45 mm/hour, alanine aminotransferase -89 U/L, aspartate 
aminotransferase -210 U/L, total bilirubin -1.04 mg/dL, 
conjugated bilirubin -0.85 mg/dL, urea -98.9 mg/dL, serum 
creatinine -3.76 mg/dL, uric acid -8.9 mg/dL and pH of 7.11. 
Further, the Plasmodium lactate dehydrogenase (pLDH) test 
was positive. Examinations of thin and thick blood smears 
(Giemsa staining) revealed the presence of ring forms typical 
for an infection with Plasmodium vivax (P. falciparum)
(Figure 1B). Her course continued to be unfavorable with a 
diuresis of only 150 mL per 24 hours. During the 3rd-day of 
hospitalization she received symptomatic and pathogenic 
treatment associated with a specific therapy with the 
following available drugs: hydroxychloroquine (4 伊 200 mg 
on the first day), halofantrine hydrochloride (Halfan) (3 伊 
500 mg on the second day), artesunate (150 mg on the third 
day) and doxycycline (2 伊 100 mg on the first day and 100 mg 
per day during the next 2 days). Because patient condition 
worsened progressively (renal, digestive and cardiovascular 
severe disturbances) and the oxygen saturation decreased, 
on the 3rd day of hospitalization patient was first transferred 
to hospital’s intensive care unit and afterwards to the 
County Emergency Hospital for performing dialysis. Patient 
died 3 hours later at the County Emergency Hospital. The 
ID Hospital discharge diagnoses were severe malaria with
P. falciparum, acute respiratory failure, acute renal failure, 
metabolic acidosis, severe thrombocytopenia, leucopenia, 
steatohepatitis and rheumatoid polyarthritis.     
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3. Discussion
  P. falciparum is the most prevalent species in Africa[4,5] 
and during 1980-2007, 67.7% of the Romanian travelers 
acquired an infection with this species[3]. Moreover, recently 
2 other fatal imported malaria cases were diagnosed in this 
region[6]. As regards the infections with P. vivax, this species 
was identified in 7.14% of cases diagnosed in a Western 
Romanian study[6]. As shown by Schmid et al.[7], travels to 
India are associated with health risks including malaria.  
  Of the 2 cases presented in this report, patient infected 
with P. falciparum had an evolution with numerous 
complications. 
  None of our patients was aware about the importance of 
considering the chemoprophylaxis. As previously shown in 
a 2-year national surveillance study of imported cases[8], 
92% of the 25 confirmed malaria cases, did not follow 
complete or incomplete chemoprophylaxis. Nevertheless, 
no fatalities were detected as unfortunately was the case for 
one of our patients. Other investigators, have also reported 
that 89.1%[9], 83.8%[10], 75%[11] and 70.8%[12] of the travelers 
diagnosed with imported malaria did not follow prophylaxis. 
In Romania, voyagers to tropical countries may freely 
benefit of medical pre-travel advice and prophylaxis[8]. The 
most recommended drug for travelers to malaria endemic 
regions is Doxycycline; this drug is considered a good 
option for areas with chloroquine or multidrug-resistant
P. falciparum[13].     
  The cases presented in this report revealed the difficulties 
in establishing a correct diagnosis of malaria in a non-
endemic country, consequences of an incomplete taken 
anamnesis. Travel history should always represent a 
mandatory part of a well conducted investigation. Lack of 
considering such an issue may lead to significant diagnostic 
delays, as it happened especially in our first case herein 
described: the patient was not guided properly from the 
beginning to an ID-target hospital. At the same time, we 
must underline the importance of a correct and complete 
prophylaxis prior to every departure to tropical countries. 
On contrary, cases related to imported exotic pathology will 
occur more frequently in the near future. 
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